Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 80

1.

Addition of cyclic angiotensin-(1-7) to angiotensin-converting enzyme inhibitor therapy has a positive add-on effect in experimental diabetic nephropathy.

Cassis P, Locatelli M, Corna D, Villa S, Rottoli D, Cerullo D, Abbate M, Remuzzi G, Benigni A, Zoja C.

Kidney Int. 2019 May 10. pii: S0085-2538(19)30486-7. doi: 10.1016/j.kint.2019.04.024. [Epub ahead of print]

PMID:
31307778
2.

Sirt3 Deficiency Shortens Life Span and Impairs Cardiac Mitochondrial Function Rescued by Opa1 Gene Transfer.

Benigni A, Cassis P, Conti S, Perico L, Corna D, Cerullo D, Zentilin L, Zoja C, Perna A, Lionetti V, Giacca M, Trionfini P, Tomasoni S, Remuzzi G.

Antioxid Redox Signal. 2019 Aug 2. doi: 10.1089/ars.2018.7703. [Epub ahead of print]

PMID:
31269804
3.

Therapeutic potential of stromal cells of non-renal or renal origin in experimental chronic kidney disease.

Rota C, Morigi M, Cerullo D, Introna M, Colpani O, Corna D, Capelli C, Rabelink TJ, Leuning DG, Rottoli D, Benigni A, Zoja C, Remuzzi G.

Stem Cell Res Ther. 2018 Aug 14;9(1):220. doi: 10.1186/s13287-018-0960-8.

4.

SGLT2 inhibitor dapagliflozin limits podocyte damage in proteinuric nondiabetic nephropathy.

Cassis P, Locatelli M, Cerullo D, Corna D, Buelli S, Zanchi C, Villa S, Morigi M, Remuzzi G, Benigni A, Zoja C.

JCI Insight. 2018 Aug 9;3(15). pii: 98720. doi: 10.1172/jci.insight.98720. eCollection 2018 Aug 9.

5.

ADAMTS13 Deficiency Shortens the Life Span of Mice With Experimental Diabetes.

Cassis P, Cerullo D, Zanchi C, Corna D, Lionetti V, Giordano F, Novelli R, Conti S, Casieri V, Matteucci M, Locatelli M, Taraboletti G, Villa S, Gastoldi S, Remuzzi G, Benigni A, Zoja C.

Diabetes. 2018 Oct;67(10):2069-2083. doi: 10.2337/db17-1508. Epub 2018 Jul 5.

6.

Human mesenchymal stromal cells transplanted into mice stimulate renal tubular cells and enhance mitochondrial function.

Perico L, Morigi M, Rota C, Breno M, Mele C, Noris M, Introna M, Capelli C, Longaretti L, Rottoli D, Conti S, Corna D, Remuzzi G, Benigni A.

Nat Commun. 2017 Oct 17;8(1):983. doi: 10.1038/s41467-017-00937-2.

7.

A previously unrecognized role of C3a in proteinuric progressive nephropathy.

Morigi M, Locatelli M, Rota C, Buelli S, Corna D, Rizzo P, Abbate M, Conti D, Perico L, Longaretti L, Benigni A, Zoja C, Remuzzi G.

Sci Rep. 2016 Jun 27;6:28445. doi: 10.1038/srep28445.

8.

Simplified Method to Measure Glomerular Filtration Rate by Iohexol Plasma Clearance in Conscious Rats.

Carrara F, Azzollini N, Nattino G, Corna D, Villa S, Cerullo D, Zoja C, Abrante B, Luis-Lima S, Porrini E, Cannata A, Ferrari S, Fois M, Stucchi N, Gaspari F.

Nephron. 2016;133(1):62-70. doi: 10.1159/000445843. Epub 2016 May 4.

PMID:
27160992
9.

Therapy with a Selective Cannabinoid Receptor Type 2 Agonist Limits Albuminuria and Renal Injury in Mice with Type 2 Diabetic Nephropathy.

Zoja C, Locatelli M, Corna D, Villa S, Rottoli D, Nava V, Verde R, Piscitelli F, Di Marzo V, Fingerle J, Adam JM, Rothenhaeusler B, Ottaviani G, Bénardeau A, Abbate M, Remuzzi G, Benigni A.

Nephron. 2016;132(1):59-69. doi: 10.1159/000442679. Epub 2015 Dec 9.

PMID:
26646377
10.

Functional Human Podocytes Generated in Organoids from Amniotic Fluid Stem Cells.

Xinaris C, Benedetti V, Novelli R, Abbate M, Rizzo P, Conti S, Tomasoni S, Corna D, Pozzobon M, Cavallotti D, Yokoo T, Morigi M, Benigni A, Remuzzi G.

J Am Soc Nephrol. 2016 May;27(5):1400-11. doi: 10.1681/ASN.2015030316. Epub 2015 Oct 29.

11.

B7-1 Is Not Induced in Podocytes of Human and Experimental Diabetic Nephropathy.

Gagliardini E, Novelli R, Corna D, Zoja C, Ruggiero B, Benigni A, Remuzzi G.

J Am Soc Nephrol. 2016 Apr;27(4):999-1005. doi: 10.1681/ASN.2015030266. Epub 2015 Aug 28.

12.

Renal primordia activate kidney regenerative events in a rat model of progressive renal disease.

Imberti B, Corna D, Rizzo P, Xinaris C, Abbate M, Longaretti L, Cassis P, Benedetti V, Benigni A, Zoja C, Remuzzi G, Morigi M.

PLoS One. 2015 Mar 26;10(3):e0120235. doi: 10.1371/journal.pone.0120235. eCollection 2015.

13.

Effects of MCP-1 inhibition by bindarit therapy in a rat model of polycystic kidney disease.

Zoja C, Corna D, Locatelli M, Rottoli D, Pezzotta A, Morigi M, Zanchi C, Buelli S, Guglielmotti A, Perico N, Remuzzi A, Remuzzi G.

Nephron. 2015;129(1):52-61. doi: 10.1159/000369149. Epub 2014 Dec 17.

14.

Shiga toxin promotes podocyte injury in experimental hemolytic uremic syndrome via activation of the alternative pathway of complement.

Locatelli M, Buelli S, Pezzotta A, Corna D, Perico L, Tomasoni S, Rottoli D, Rizzo P, Conti D, Thurman JM, Remuzzi G, Zoja C, Morigi M.

J Am Soc Nephrol. 2014 Aug;25(8):1786-98. doi: 10.1681/ASN.2013050450. Epub 2014 Feb 27.

15.

β-arrestin-1 drives endothelin-1-mediated podocyte activation and sustains renal injury.

Buelli S, Rosanò L, Gagliardini E, Corna D, Longaretti L, Pezzotta A, Perico L, Conti S, Rizzo P, Novelli R, Morigi M, Zoja C, Remuzzi G, Bagnato A, Benigni A.

J Am Soc Nephrol. 2014 Mar;25(3):523-33. doi: 10.1681/ASN.2013040362. Epub 2013 Dec 26.

16.

Renal expression of FGF23 in progressive renal disease of diabetes and the effect of ACE inhibitor.

Zanchi C, Locatelli M, Benigni A, Corna D, Tomasoni S, Rottoli D, Gaspari F, Remuzzi G, Zoja C.

PLoS One. 2013 Aug 14;8(8):e70775. doi: 10.1371/journal.pone.0070775. eCollection 2013.

17.

Analogs of bardoxolone methyl worsen diabetic nephropathy in rats with additional adverse effects.

Zoja C, Corna D, Nava V, Locatelli M, Abbate M, Gaspari F, Carrara F, Sangalli F, Remuzzi G, Benigni A.

Am J Physiol Renal Physiol. 2013 Mar 15;304(6):F808-19. doi: 10.1152/ajprenal.00376.2012. Epub 2012 Nov 7.

18.

In vivo maturation of functional renal organoids formed from embryonic cell suspensions.

Xinaris C, Benedetti V, Rizzo P, Abbate M, Corna D, Azzollini N, Conti S, Unbekandt M, Davies JA, Morigi M, Benigni A, Remuzzi G.

J Am Soc Nephrol. 2012 Nov;23(11):1857-68. doi: 10.1681/ASN.2012050505. Epub 2012 Oct 18.

19.

Mesenchymal stem cell therapy promotes renal repair by limiting glomerular podocyte and progenitor cell dysfunction in adriamycin-induced nephropathy.

Zoja C, Garcia PB, Rota C, Conti S, Gagliardini E, Corna D, Zanchi C, Bigini P, Benigni A, Remuzzi G, Morigi M.

Am J Physiol Renal Physiol. 2012 Nov 1;303(9):F1370-81. doi: 10.1152/ajprenal.00057.2012. Epub 2012 Sep 5.

20.

Lack of the lectin-like domain of thrombomodulin worsens Shiga toxin-associated hemolytic uremic syndrome in mice.

Zoja C, Locatelli M, Pagani C, Corna D, Zanchi C, Isermann B, Remuzzi G, Conway EM, Noris M.

J Immunol. 2012 Oct 1;189(7):3661-8. Epub 2012 Aug 31.

21.

Distinct cardiac and renal effects of ETA receptor antagonist and ACE inhibitor in experimental type 2 diabetes.

Zoja C, Cattaneo S, Fiordaliso F, Lionetti V, Zambelli V, Salio M, Corna D, Pagani C, Rottoli D, Bisighini C, Remuzzi G, Benigni A.

Am J Physiol Renal Physiol. 2011 Nov;301(5):F1114-23. doi: 10.1152/ajprenal.00122.2011. Epub 2011 Aug 3.

22.

Effect of ACE inhibition on glomerular permselectivity and tubular albumin concentration in the renal ablation model.

Sangalli F, Carrara F, Gaspari F, Corna D, Zoja C, Botti L, Remuzzi G, Remuzzi A.

Am J Physiol Renal Physiol. 2011 Jun;300(6):F1291-300. doi: 10.1152/ajprenal.00656.2010. Epub 2011 Mar 30.

23.

Adding a statin to a combination of ACE inhibitor and ARB normalizes proteinuria in experimental diabetes, which translates into full renoprotection.

Zoja C, Corna D, Gagliardini E, Conti S, Arnaboldi L, Benigni A, Remuzzi G.

Am J Physiol Renal Physiol. 2010 Nov;299(5):F1203-11. doi: 10.1152/ajprenal.00045.2010. Epub 2010 Aug 18.

24.

Adenoviral-mediated gene transfer restores plasma ADAMTS13 antigen and activity in ADAMTS13 knockout mice.

Trionfini P, Tomasoni S, Galbusera M, Motto D, Longaretti L, Corna D, Remuzzi G, Benigni A.

Gene Ther. 2009 Nov;16(11):1373-9. doi: 10.1038/gt.2009.98. Epub 2009 Aug 13.

PMID:
19675594
25.

Unlike each drug alone, lisinopril if combined with avosentan promotes regression of renal lesions in experimental diabetes.

Gagliardini E, Corna D, Zoja C, Sangalli F, Carrara F, Rossi M, Conti S, Rottoli D, Longaretti L, Remuzzi A, Remuzzi G, Benigni A.

Am J Physiol Renal Physiol. 2009 Nov;297(5):F1448-56. doi: 10.1152/ajprenal.00340.2009. Epub 2009 Aug 12.

26.

V1/V2 Vasopressin receptor antagonism potentiates the renoprotection of renin-angiotensin system inhibition in rats with renal mass reduction.

Perico N, Zoja C, Corna D, Rottoli D, Gaspari F, Haskell L, Remuzzi G.

Kidney Int. 2009 Nov;76(9):960-7. doi: 10.1038/ki.2009.267. Epub 2009 Jul 22.

27.

Disruption of the Ang II type 1 receptor promotes longevity in mice.

Benigni A, Corna D, Zoja C, Sonzogni A, Latini R, Salio M, Conti S, Rottoli D, Longaretti L, Cassis P, Morigi M, Coffman TM, Remuzzi G.

J Clin Invest. 2009 Mar;119(3):524-30. doi: 10.1172/JCI36703. Epub 2009 Feb 9.

28.

Proteasomal processing of albumin by renal dendritic cells generates antigenic peptides.

Macconi D, Chiabrando C, Schiarea S, Aiello S, Cassis L, Gagliardini E, Noris M, Buelli S, Zoja C, Corna D, Mele C, Fanelli R, Remuzzi G, Benigni A.

J Am Soc Nephrol. 2009 Jan;20(1):123-30. doi: 10.1681/ASN.2007111233. Epub 2008 Dec 17.

29.

Human bone marrow mesenchymal stem cells accelerate recovery of acute renal injury and prolong survival in mice.

Morigi M, Introna M, Imberti B, Corna D, Abbate M, Rota C, Rottoli D, Benigni A, Perico N, Zoja C, Rambaldi A, Remuzzi A, Remuzzi G.

Stem Cells. 2008 Aug;26(8):2075-82. doi: 10.1634/stemcells.2007-0795. Epub 2008 May 22.

30.

Complement-mediated dysfunction of glomerular filtration barrier accelerates progressive renal injury.

Abbate M, Zoja C, Corna D, Rottoli D, Zanchi C, Azzollini N, Tomasoni S, Berlingeri S, Noris M, Morigi M, Remuzzi G.

J Am Soc Nephrol. 2008 Jun;19(6):1158-67. doi: 10.1681/ASN.2007060686. Epub 2008 Mar 19.

31.

Insulin-like growth factor-1 sustains stem cell mediated renal repair.

Imberti B, Morigi M, Tomasoni S, Rota C, Corna D, Longaretti L, Rottoli D, Valsecchi F, Benigni A, Wang J, Abbate M, Zoja C, Remuzzi G.

J Am Soc Nephrol. 2007 Nov;18(11):2921-8. Epub 2007 Oct 17.

32.

Effects of rosuvastatin on glomerular capillary size-selectivity function in rats with renal mass ablation.

Corna D, Sangalli F, Cattaneo D, Carrara F, Gaspari F, Remuzzi A, Zoja C, Benigni A, Perico N, Remuzzi G.

Am J Nephrol. 2007;27(6):630-8. Epub 2007 Sep 11.

PMID:
17851231
33.

Cyclin-dependent kinase inhibition limits glomerulonephritis and extends lifespan of mice with systemic lupus.

Zoja C, Casiraghi F, Conti S, Corna D, Rottoli D, Cavinato RA, Remuzzi G, Benigni A.

Arthritis Rheum. 2007 May;56(5):1629-37.

34.

Beneficial effect of TGFbeta antagonism in treating diabetic nephropathy depends on when treatment is started.

Benigni A, Zoja C, Campana M, Corna D, Sangalli F, Rottoli D, Gagliardini E, Conti S, Ledbetter S, Remuzzi G.

Nephron Exp Nephrol. 2006;104(4):e158-68. Epub 2006 Aug 10.

PMID:
16902320
35.

Imatinib ameliorates renal disease and survival in murine lupus autoimmune disease.

Zoja C, Corna D, Rottoli D, Zanchi C, Abbate M, Remuzzi G.

Kidney Int. 2006 Jul;70(1):97-103. Epub 2006 May 10.

36.

Transcriptional regulation of nephrin gene by peroxisome proliferator-activated receptor-gamma agonist: molecular mechanism of the antiproteinuric effect of pioglitazone.

Benigni A, Zoja C, Tomasoni S, Campana M, Corna D, Zanchi C, Gagliardini E, Garofano E, Rottoli D, Ito T, Remuzzi G.

J Am Soc Nephrol. 2006 Jun;17(6):1624-32. Epub 2006 May 10.

37.

Vasopeptidase inhibitor restores the balance of vasoactive hormones in progressive nephropathy.

Benigni A, Zoja C, Zatelli C, Corna D, Longaretti L, Rottoli D, Maggioni P, Todeschini M, Noris M, Remuzzi G.

Kidney Int. 2004 Nov;66(5):1959-65.

38.

Targeted deletion of angiotensin II type 1A receptor does not protect mice from progressive nephropathy of overload proteinuria.

Benigni A, Corna D, Zoja C, Longaretti L, Gagliardini E, Perico N, Coffman TM, Remuzzi G.

J Am Soc Nephrol. 2004 Oct;15(10):2666-74.

39.

Mesenchymal stem cells are renotropic, helping to repair the kidney and improve function in acute renal failure.

Morigi M, Imberti B, Zoja C, Corna D, Tomasoni S, Abbate M, Rottoli D, Angioletti S, Benigni A, Perico N, Alison M, Remuzzi G.

J Am Soc Nephrol. 2004 Jul;15(7):1794-804.

40.

Protein overload induces fractalkine upregulation in proximal tubular cells through nuclear factor kappaB- and p38 mitogen-activated protein kinase-dependent pathways.

Donadelli R, Zanchi C, Morigi M, Buelli S, Batani C, Tomasoni S, Corna D, Rottoli D, Benigni A, Abbate M, Remuzzi G, Zoja C.

J Am Soc Nephrol. 2003 Oct;14(10):2436-46.

41.

Combining lisinopril and l-arginine slows disease progression and reduces endothelin-1 in passive Heymann nephritis.

Zoja C, Benigni A, Camozzi D, Corna D, Longaretti L, Todeschini M, Remuzzi G.

Kidney Int. 2003 Sep;64(3):857-63.

42.

Add-on anti-TGF-beta antibody to ACE inhibitor arrests progressive diabetic nephropathy in the rat.

Benigni A, Zoja C, Corna D, Zatelli C, Conti S, Campana M, Gagliardini E, Rottoli D, Zanchi C, Abbate M, Ledbetter S, Remuzzi G.

J Am Soc Nephrol. 2003 Jul;14(7):1816-24.

43.

How to fully protect the kidney in a severe model of progressive nephropathy: a multidrug approach.

Zoja C, Corna D, Camozzi D, Cattaneo D, Rottoli D, Batani C, Zanchi C, Abbate M, Remuzzi G.

J Am Soc Nephrol. 2002 Dec;13(12):2898-908.

44.

Proximal tubular cells promote fibrogenesis by TGF-beta1-mediated induction of peritubular myofibroblasts.

Abbate M, Zoja C, Rottoli D, Corna D, Tomasoni S, Remuzzi G.

Kidney Int. 2002 Jun;61(6):2066-77. Erratum in: Kidney Int 2002 Aug;62(2):731.

45.

Effect of combining ACE inhibitor and statin in severe experimental nephropathy.

Zoja C, Corna D, Rottoli D, Cattaneo D, Zanchi C, Tomasoni S, Abbate M, Remuzzi G.

Kidney Int. 2002 May;61(5):1635-45.

47.

Mycophenolate mofetil combined with a cyclooxygenase-2 inhibitor ameliorates murine lupus nephritis.

Zoja C, Benigni A, Noris M, Corna D, Casiraghi F, Pagnoncelli M, Rottoli D, Abbate M, Remuzzi G.

Kidney Int. 2001 Aug;60(2):653-63.

48.

Protein traffic activates NF-kB gene signaling and promotes MCP-1-dependent interstitial inflammation.

Donadelli R, Abbate M, Zanchi C, Corna D, Tomasoni S, Benigni A, Remuzzi G, Zoja C.

Am J Kidney Dis. 2000 Dec;36(6):1226-41.

PMID:
11096048
49.

17beta-estradiol corrects hemostasis in uremic rats by limiting vascular expression of nitric oxide synthases.

Noris M, Todeschini M, Zappella S, Bonazzola S, Zoja C, Corna D, Gaspari F, Marchetti G, Aiello S, Remuzzi G.

Am J Physiol Renal Physiol. 2000 Oct;279(4):F626-35. Erratum in: Am J Physiol Renal Physiol 2001 Feb;280(2):preceding F181. Am J Physiol Renal Physiol 2001 Jun;280(6):section F following table of contents. Marchetti, F [corrected to Marchetti, G].

50.

Angiotensin-converting enzyme inhibition prevents loss of glomerular hydraulic permeability in passive heymann nephritis.

Remuzzi A, Monaci N, Bonassi ME, Corna D, Zoja C, Mohammed EI, Remuzzi G.

Lab Invest. 1999 Dec;79(12):1501-10.

PMID:
10616201

Supplemental Content

Support Center